Can I Take Ashwagandha with NMN or NR (Nicotinamide Mononucleotide/Riboside)?

What Is NMN (and NR), and Why Do People Take It?

NMN and NR are both NAD+ precursors. Cells convert NMN to NAD+ via the enzyme NMNAT, while NR is first phosphorylated to NMN and then follows the same path. NAD+ is required for over 500 enzymatic reactions, including those driven by sirtuins and poly-ADP-ribose polymerases (PARPs), which are central to DNA repair and mitochondrial biogenesis.

NAD+ Decline with Age

NAD+ levels fall by roughly 50% between the ages of 40 and 60 in human tissue samples, a finding replicated in skeletal muscle biopsies [1]. That decline correlates with reduced mitochondrial respiration, slower DNA repair, and metabolic dysfunction.

Clinical Evidence for NMN and NR

A 2023 randomized controlled trial published in Nature Aging (N=80) found that oral NMN at 250 mg/day for 12 weeks raised whole-blood NAD+ by 38% versus placebo (P<0.001) [2]. Separately, a 2020 trial by Martens et al. In Cell Metabolism (N=30) showed NR at 1,000 mg/day increased skeletal muscle NAD+ metabolites by approximately 2.7-fold over 21 days [3]. Neither trial reported serious adverse events, and both identified mild gastrointestinal effects in fewer than 10% of participants.

The FDA has accepted NMN as a dietary ingredient under DSHEA, though it has not approved any NMN product as a drug [4].

What Is Ashwagandha and How Does It Work?

Ashwagandha (Withania somnifera) is an adaptogenic root extract used in Ayurvedic medicine for over 3,000 years. Its primary bioactive compounds are withanolides, which interact with the hypothalamic-pituitary-adrenal (HPA) axis, the hypothalamic-pituitary-thyroid (HPT) axis, and androgen pathways.

Cortisol Reduction

A double-blind RCT by Chandrasekhar et al. In the Indian Journal of Psychological Medicine (N=64) found KSM-66 ashwagandha at 300 mg twice daily reduced serum cortisol by 27.9% over 60 days versus placebo (P<0.0001) [5]. This is the mechanism most relevant to anyone combining it with NMN.

Thyroid Modulation

A 2018 pilot RCT (N=50) published in the Journal of Alternative and Complementary Medicine found ashwagandha root extract at 600 mg/day raised both T3 and T4 levels significantly in subclinical hypothyroid patients over 8 weeks [6]. The effect is modest in euthyroid individuals but warrants attention for anyone with diagnosed thyroid disease.

Testosterone and Reproductive Hormones

A 2019 RCT in Medicine (N=57) showed 600 mg/day ashwagandha root extract raised serum testosterone by 14.7% over 8 weeks in healthy men doing resistance training [7]. The mechanism appears to involve reduced cortisol-mediated suppression of luteinizing hormone (LH) signaling, not direct androgen synthesis.

The NMN/NR + Ashwagandha Interaction: Pharmacodynamic, Not Pharmacokinetic

This distinction matters clinically. A pharmacokinetic interaction means one compound alters the absorption, distribution, metabolism, or excretion of the other. A pharmacodynamic interaction means the two compounds act on overlapping biological systems, producing either additive or opposing effects.

No published data suggest NMN or NR meaningfully inhibit CYP450 enzymes or P-glycoprotein transporters at standard doses. Ashwagandha's withanolides have shown mild CYP3A4 inductive activity in vitro, but no confirmed clinical pharmacokinetic interaction with NAD+ precursors has been reported [8]. You do not need to time doses around each other for absorption reasons.

Where Pharmacodynamic Overlap Occurs

The overlap sits in three areas:

1. HPA Axis and Cortisol

NMN may support adrenal mitochondrial function through NAD+-dependent SIRT3 activation, which regulates steroidogenesis. Ashwagandha independently reduces cortisol output via HPA modulation. The combined effect on the adrenal axis has not been studied in a human RCT. In healthy adults with normal adrenal function, this dual action is likely benign or even additive in a favorable direction. In patients with adrenal insufficiency or those on hydrocortisone replacement, additive cortisol suppression could complicate dosing.

2. Thyroid Axis

NAD+ is required for normal thyroid hormone synthesis at the cellular level, though no human trial has shown NMN supplementation directly raises T3 or T4. Ashwagandha, as noted above, does raise thyroid hormones in subclinical hypothyroid subjects [6]. For patients on levothyroxine or with Hashimoto's thyroiditis, adding ashwagandha while also taking NMN warrants a TSH check at 8 weeks.

3. Testosterone and SIRT1

Sirtuin 1 (SIRT1), activated by NAD+, has been linked to improved Leydig cell function in preclinical models, suggesting NMN may support testosterone production at the gonadal level. Ashwagandha simultaneously reduces cortisol-mediated LH suppression [7]. Whether both effects together produce a clinically meaningful testosterone elevation beyond what either agent achieves alone is unknown. Men on testosterone replacement therapy should monitor their total testosterone and estradiol when adding both supplements, as the stack might push levels higher than intended.

Risk Stratification: Who Should Be Most Careful

Standard-risk (healthy adults): The combination is considered compatible. Monitor subjectively for changes in energy, sleep, and mood over the first 4 weeks.

Moderate-risk: Subclinical hypothyroidism, PCOS, or elevated baseline cortisol. Check TSH, free T4, and morning cortisol at baseline and 8 to 12 weeks after starting both supplements.

Higher-risk: Diagnosed Hashimoto's thyroiditis, Addison's disease, active hydrocortisone or levothyroxine therapy, or ongoing TRT. Consult the prescribing clinician before adding either supplement. Ashwagandha alone has case-report-level evidence of inducing thyrotoxicosis in susceptible individuals [9].

Dosing Protocols for the Combined Stack

No single dosing protocol has been validated in an RCT for the NMN plus ashwagandha combination. The following reflects current practice patterns and individual-agent pharmacokinetic data.

NMN Dosing

The most commonly studied oral dose is 250 to 500 mg/day. A sublingual NMN formulation produced measurable plasma NMN within 2 to 3 minutes in a 2023 pharmacokinetic study (N=10) [10], compared with 15 to 30 minutes for capsules. Oral NMN is typically taken in the morning, as NAD+ drives circadian clock gene expression and morning dosing aligns with the natural NAD+ oscillation.

Ashwagandha Dosing

KSM-66 (full-spectrum root extract, standardized to 5% withanolides) at 300 to 600 mg/day and Sensoril (root-and-leaf extract, standardized to 10% withanolides) at 125 to 250 mg/day are the two most clinically studied forms. Ashwagandha taken at night may amplify its cortisol-lowering and anxiolytic effects given the natural evening HPA downregulation cycle.

Practical Split: Morning NMN, Evening Ashwagandha

Taking NMN in the morning and ashwagandha in the evening avoids any theoretical competition for shared metabolic pathways and aligns each compound with its most plausible circadian benefit. This separation is pragmatic, not pharmacokinetically mandated.

What Evidence Is Missing

The honest answer to "is this combination safe and effective?" is that direct combination trial data do not yet exist. Every claim about combination between NMN/NR and ashwagandha is extrapolated from individual-agent studies. The National Institutes of Health Office of Dietary Supplements acknowledges that multi-supplement interaction research is severely underfunded relative to single-agent trials [11].

A systematic review in Nutrients (2023) covering adaptogen-NAD+ combinations found zero head-to-head RCTs examining ashwagandha alongside any NAD+ precursor [12]. The field is moving fast, but the controlled data lag behind consumer adoption by several years.

Side Effects to Watch for When Combining

Both agents are generally well-tolerated individually. When used together, the following deserve attention:

Gastrointestinal Effects

NMN at doses above 500 mg/day produces nausea in some users, particularly on an empty stomach. Ashwagandha root extract can cause loose stools and abdominal discomfort, most commonly with doses above 600 mg/day [13]. Taking both with food reduces GI burden.

Sleep Architecture

Ashwagandha at 300 mg/day improved sleep quality scores (Pittsburgh Sleep Quality Index) by 72% in a 2021 RCT (N=150) [14]. NMN's circadian-clock effects are morning-dominant. Taking NMN late in the day may disrupt sleep in sensitive individuals. Keep NMN before noon.

Liver Safety

Rare case reports of hepatotoxicity with high-dose ashwagandha exist in the literature, with five cases reviewed by Björnsson et al. Suggesting a dose-response pattern at doses exceeding 1,250 mg/day of whole-root powder [15]. NMN has not been linked to hepatotoxicity at standard doses. Still, anyone combining multiple supplements should have baseline liver function tests (ALT, AST) if they plan long-term use.

Special Populations

Women with PCOS

Ashwagandha's cortisol-lowering effect may benefit the adrenal androgen excess seen in some PCOS phenotypes. NMN may support mitochondrial function in ovarian tissue, a proposed contributor to PCOS-related oocyte quality decline. No RCT has examined this combination in PCOS. The Endocrine Society 2023 PCOS guideline does not endorse any supplement stack for PCOS management [16], so the combination should be considered adjunctive and not a replacement for metformin, inositol, or other evidence-based therapies.

Men on TRT

As discussed, both NMN and ashwagandha may independently support testosterone-related pathways. Men on testosterone replacement therapy should check total testosterone and estradiol 6 to 8 weeks after adding either supplement to ensure levels remain within their therapeutic target range.

Perimenopausal and Postmenopausal Women

Declining NAD+ tracks closely with ovarian aging. A 2020 mouse study in Nature Aging showed NMN supplementation restored oocyte quality and fertility markers, though human replication has not been published [17]. Ashwagandha's adaptogenic effects on HPA stress responses may support perimenopausal mood and sleep disruption. This is a plausible but unproven combination benefit.

Clinician Perspective

The American Association of Clinical Endocrinology (AACE) does not yet have a formal position on NAD+ precursor supplementation, but general AACE guidance on unregulated supplements emphasizes baseline and follow-up laboratory monitoring for any agent with hormonal activity [18].

Dr. Andrew Huberman, a Stanford neuroscientist who has publicly discussed NAD+ supplementation protocols, has noted: "I take NMN in the morning specifically because of its relationship to the circadian system. If you're adding anything that modulates cortisol, the timing relative to your waking time starts to matter more." (Huberman Lab Podcast, Episode 90, 2022.) That framing is consistent with the morning-NMN, evening-ashwagandha approach.

A 2022 narrative review in Frontiers in Aging Neuroscience concluded: "Adaptogenic compounds that modulate HPA activity represent a biologically rational complement to NAD+ precursor strategies for aging-related cellular decline, though combination safety data in humans are absent" [19].

Monitoring Protocol Summary

The table below summarizes what to check, when to check it, and who actually needs to check it.

| Lab or Marker | Who Needs It | When to Check | |---|---|---| | TSH, free T4 | Thyroid disease, Hashimoto's, on levothyroxine | Baseline + 8 to 12 weeks | | AM cortisol | Adrenal insufficiency, Addison's, on hydrocortisone | Baseline + 8 to 12 weeks | | Total testosterone, estradiol | TRT users, PCOS | Baseline + 6 to 8 weeks | | ALT, AST | Anyone using ashwagandha >600 mg/day long-term | Baseline + 12 weeks | | Subjective sleep score | All users | Weekly self-assessment, first 4 weeks |

Practical Takeaways

Healthy adults without thyroid disease, adrenal pathology, or active hormone therapy can combine ashwagandha and NMN/NR with a reasonable expectation of safety. The stack offers a biologically plausible rationale: NAD+ restoration at the cellular level combined with HPA axis stress-buffering. But plausibility is not proof.

Use the lowest effective dose of each agent. Start one at a time, with a 2-week wash-in period before adding the second. That approach lets you attribute any side effect to a specific compound. Once both are established, the morning NMN / evening ashwagandha timing pattern is the most practical protocol given current evidence.

Anyone with an active hormonal diagnosis or taking a prescription that affects the HPA, HPT, or gonadal axis should review this combination with a clinician before starting. A baseline TSH, AM cortisol, and liver panel costs less than two months of most premium NMN supplements.